FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Ajanta Pharma Buyback 2024 and Sharda Motor Industries Buyback 2024.
Ajanta Pharma Buyback 2024 is a Tender Offer buyback proposed to list at BSE, NSE while Sharda Motor Industries Buyback 2024 is a Tender Offer proposed to list at BSE, NSE.
Ajanta Pharma Limited | Sharda Motor Industries Ltd | |
---|---|---|
Logo | ||
Type of Buyback | Tender Offer | Tender Offer |
Listing At | BSE, NSE | BSE, NSE |
Face Value | ₹2 per share | ₹2 per share |
Buyback Price | ₹2770 per share | ₹1800 per share |
Issue Size | 10,28,881 shares | 10,27,777 shares |
Issue Size (Amount) | ₹285.00 Crores | ₹185.00 Crores |
Buyback Ratio | ||
Registrar | Link Intime India Private Ltd | |
Lead Managers | Vivro Financial Services Private Limited | |
Necessity of the buyback | Buyback is being undertaken, inter-alia, for the following reasons:
|
Ajanta Pharma Buyback 2024 and Sharda Motor Industries Buyback 2024 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Ajanta Pharma Buyback 2024 Buyback record date is May 30, 2024. Sharda Motor Industries Buyback 2024 Buyback record date is .
Ajanta Pharma Limited | Sharda Motor Industries Ltd | |
---|---|---|
Record Date | May 30, 2024 | |
Offer Open Date | ||
Offer Closure Date | ||
Last date for receipt of tender forms | ||
Finalisation of buyback | ||
Last Date for settlment of bids | ||
Last Date for extinguishment of shares |
Comparison of Ajanta Pharma Buyback 2024 and Sharda Motor Industries Buyback 2024 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.
Ajanta Pharma Limited | Sharda Motor Industries Ltd | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Ajanta Pharma Limited Financial Information (Restated Consolidated)Ajanta Pharma Limited's revenue increased by 11.77% and profit after tax (PAT) rose by 38.81% between the financial year ending with March 31, 2024 and March 31, 2023.
|
Sharda Motor Industries Ltd Financial Information (Restated)
|
|||||||||||||||||||||||||||||||||||||||
Stock price at BSE | |||||||||||||||||||||||||||||||||||||||||
Stock price at NSE |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|